Back
Logitech International SA Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
67
LOGI
Logitech International SA
Last Price:
95.95
Seasonality Move:
-2.93%
Sell
44
RARE
Ultragenyx Pharmaceutical
Last Price:
41.54
Seasonality Move:
-0.9%
Buy
67
Logitech International SA (LOGI)
is a Buy
Is Logitech International SA a Buy, Sell or Hold?
- The current Logitech International SA [LOGI] share price is $96.32. The Score for LOGI is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- LOGI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LOGI Stock Price Chart
What is Logitech International SA's stock price today?
-
The Logitech International SA share price today is $96.32
The current trend is moderately bearish and LOGI is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $40.50
The current trend is relatively stagnant and RARE is experiencing slight buying pressure.
LOGI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.52 | Buy |
Relative Strength Index (14 RSI): | 49.99 | Sell |
Chaikin Money Flow: | 150135 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (95.55 - 100.65) | Sell |
Bollinger Bands (100): | (82.88 - 95.68) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 49.22 | Sell |
Chaikin Money Flow: | 494801 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.79 - 41.97) | Buy |
Bollinger Bands (100): | (40.81 - 48.79) | Sell |
LOGI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 97.77 | Sell |
20-day SMA: | 98.94 | Sell |
50-day SMA: | 90.35 | Buy |
200-day SMA: | 85.76 | Buy |
8-day EMA: | 97.8 | Sell |
20-day EMA: | 97.32 | Sell |
50-day EMA: | 93.59 | Buy |
200-day EMA: | 85.15 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.2 | Buy |
20-day SMA: | 40.42 | Buy |
50-day SMA: | 41.53 | Sell |
200-day SMA: | 42.45 | Sell |
8-day EMA: | 39.89 | Buy |
20-day EMA: | 40.39 | Buy |
50-day EMA: | 41.79 | Sell |
200-day EMA: | 43.35 | Sell |
Logitech International SA Earnings Growth & LOGI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.31 per share, an increase this year of $0.77 per share, and an increase next year of $0.34 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Logitech International SA Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |